메뉴 건너뛰기




Volumn 2, Issue 10, 2014, Pages e554-e556

Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE DURATION; DISEASE TRANSMISSION; ECONOMIC ASPECT; GROSS NATIONAL PRODUCT; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LIFESPAN; LIGHT EMITTING DIODE; MULTIDRUG RESISTANT TUBERCULOSIS; NOTE; ORGANIZATION AND MANAGEMENT; SPUTUM SMEAR; TUBERCULOSIS; XPERT MTB RIF ASSAY; DEVICES; ECONOMICS; FLUORESCENCE MICROSCOPY; MICROBIOLOGY; SPUTUM;

EID: 84907279823     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70305-5     Document Type: Note
Times cited : (10)

References (19)
  • 1
    • 84874887247 scopus 로고    scopus 로고
    • Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
    • Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014, 1.
    • (2014) Cochrane Database Syst Rev , pp. 1
    • Steingart, K.R.1    Sohn, H.2    Schiller, I.3
  • 2
    • 79960509329 scopus 로고    scopus 로고
    • Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting
    • Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011, 184:132-140.
    • (2011) Am J Respir Crit Care Med , vol.184 , pp. 132-140
    • Theron, G.1    Peter, J.2    van Zyl-Smit, R.3
  • 3
    • 84907270362 scopus 로고    scopus 로고
    • Diagnostic delays and clinical decision-making with centralized Xpert MTB/RIF testing in Durban, South Africa
    • Published online August 12.
    • Cohen GM, Drain PK, Noubary F, Cloete C, Bassett IV Diagnostic delays and clinical decision-making with centralized Xpert MTB/RIF testing in Durban, South Africa. J Acquir Imm Defic Syndr 2014, Published online August 12. http://dx.doi.org/10.1097/QAI.0000000000000309.
    • (2014) J Acquir Imm Defic Syndr
    • Cohen, G.M.1    Drain, P.K.2    Noubary, F.3    Cloete, C.4    Bassett, I.V.5
  • 5
    • 84885665977 scopus 로고    scopus 로고
    • Tuberculosis
    • Scully T Tuberculosis. Nature 2013, 502:S1-SS.
    • (2013) Nature , vol.502 , pp. S1-SS
    • Scully, T.1
  • 6
    • 84895071180 scopus 로고    scopus 로고
    • Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
    • Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014, 383:424-435.
    • (2014) Lancet , vol.383 , pp. 424-435
    • Theron, G.1    Zijenah, L.2    Chanda, D.3
  • 7
    • 84901058039 scopus 로고    scopus 로고
    • Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?
    • Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?. Lancet Infect Dis 2014, 14:527-532.
    • (2014) Lancet Infect Dis , vol.14 , pp. 527-532
    • Theron, G.1    Peter, J.2    Dowdy, D.3    Langley, I.4    Squire, S.B.5    Dheda, K.6
  • 8
    • 84863461477 scopus 로고    scopus 로고
    • Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
    • Theron G, Pooran A, Peter J, et al. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?. Eur Respir J 2012, 40:161-168.
    • (2012) Eur Respir J , vol.40 , pp. 161-168
    • Theron, G.1    Pooran, A.2    Peter, J.3
  • 9
    • 84883524366 scopus 로고    scopus 로고
    • Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
    • Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J 2013, 42:708-720.
    • (2013) Eur Respir J , vol.42 , pp. 708-720
    • Pantoja, A.1    Fitzpatrick, C.2    Vassall, A.3    Weyer, K.4    Floyd, K.5
  • 10
    • 82455205785 scopus 로고    scopus 로고
    • Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis
    • Vassall A, van Kampen S, Sohn H, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 2011, 8:e1001120.
    • (2011) PLoS Med , vol.8 , pp. e1001120
    • Vassall, A.1    van Kampen, S.2    Sohn, H.3
  • 11
    • 84870266092 scopus 로고    scopus 로고
    • Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
    • Menzies NA, Cohen T, Lin H-H, Murray M, Salomon JA Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 2012, 9:e1001347.
    • (2012) PLoS Med , vol.9 , pp. e1001347
    • Menzies, N.A.1    Cohen, T.2    Lin, H.-H.3    Murray, M.4    Salomon, J.A.5
  • 12
    • 84907262438 scopus 로고    scopus 로고
    • Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
    • Langley I, Lin H-H, Egwaga S, et al. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Glob Health 2014, 2:e581-e591.
    • (2014) Lancet Glob Health , vol.2 , pp. e581-e591
    • Langley, I.1    Lin, H.-H.2    Egwaga, S.3
  • 13
    • 34250314931 scopus 로고    scopus 로고
    • Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
    • Getahun H, Harrington M, O'Brien R, Nunn P Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007, 369:2042-2049.
    • (2007) Lancet , vol.369 , pp. 2042-2049
    • Getahun, H.1    Harrington, M.2    O'Brien, R.3    Nunn, P.4
  • 14
    • 84867133991 scopus 로고    scopus 로고
    • The impact of new tuberculosis diagnostics on transmission: why context matters
    • Lin H-H, Dowdy D, Dye C, Murray M, Cohen T The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ 2012, 90:739-747.
    • (2012) Bull World Health Organ , vol.90 , pp. 739-747
    • Lin, H.-H.1    Dowdy, D.2    Dye, C.3    Murray, M.4    Cohen, T.5
  • 15
    • 80055028625 scopus 로고    scopus 로고
    • Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm
    • Swai HF, Mugusi FM, Mbwambo JK Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm. BMC Res Notes 2011, 4:475.
    • (2011) BMC Res Notes , vol.4 , pp. 475
    • Swai, H.F.1    Mugusi, F.M.2    Mbwambo, J.K.3
  • 16
    • 84886470418 scopus 로고    scopus 로고
    • Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis
    • Walusimbi S, Bwanga F, De Costa A, Haile M, Joloba M, Hoffner S Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis 2013, 13:507.
    • (2013) BMC Infect Dis , vol.13 , pp. 507
    • Walusimbi, S.1    Bwanga, F.2    De Costa, A.3    Haile, M.4    Joloba, M.5    Hoffner, S.6
  • 17
    • 84883607703 scopus 로고    scopus 로고
    • Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult tuberculosis suspects in Uganda
    • Nakiyingi L, Bwanika JM, Kirenga B, et al. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult tuberculosis suspects in Uganda. PLOS One 2013, 8:e74023.
    • (2013) PLOS One , vol.8 , pp. e74023
    • Nakiyingi, L.1    Bwanika, J.M.2    Kirenga, B.3
  • 18
    • 84871303261 scopus 로고    scopus 로고
    • Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting
    • Huerga H, Varaine F, Okwaro E, et al. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting. PLoS One 2012, 7:e51336.
    • (2012) PLoS One , vol.7 , pp. e51336
    • Huerga, H.1    Varaine, F.2    Okwaro, E.3
  • 19
    • 84868702003 scopus 로고    scopus 로고
    • Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review
    • Barter D, Agboola S, Murray M, Barnighausen T Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review. BMC Public Health 2012, 12:980.
    • (2012) BMC Public Health , vol.12 , pp. 980
    • Barter, D.1    Agboola, S.2    Murray, M.3    Barnighausen, T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.